GLA
HRMY icon

Great Lakes Advisors’s Harmony Biosciences HRMY Stock Holding History

Great Lakes Advisors’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-141,301
Closed -$4.56M – 827
2023
Q4 		$4.56M Sell
141,301
-139,867
-50% -$3.9M 0.04% 332
2023
Q3 		$9.21M Sell
281,168
-31,879
-10% -$1.11M 0.08% 210
2023
Q2 		$11M Sell
313,047
-93,133
-23% -$3.22M 0.11% 194
2023
Q1 		$13.3M Buy
406,180
+248,651
+158% +$11.3M 0.12% 158
2022
Q4 		$8.68M Sell
157,529
-2,034
-1% -$112K 0.5% 24
2022
Q3 		$7.07M Sell
159,563
-6,775
-4% -$330K 0.15% 173
2022
Q2 		$8.11M Buy
+166,338
New +$7.49M 0.16% 161

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Great Lakes Advisors's HRMY Position: Q1 2024 in Review

Great Lakes Advisors sold out of Harmony Biosciences (HRMY) in Q1 2024, closing a stake of 141,301 shares — an estimated $4.56M sold.

Great Lakes Advisors first reported a position in HRMY in Q2 2022 and held it in 7 quarters. The position peaked at $13.3M in Q1 2023. 208 funds tracked by Wall St. Rank hold HRMY as of Q1 2024.

  • Great Lakes Advisors reported no remaining Harmony Biosciences position as of Q1 2024 after selling out during the quarter.
  • Great Lakes Advisors sold 141,301 Harmony Biosciences shares in Q1 2024, an estimated $4.56M.
  • Great Lakes Advisors first reported a position in Harmony Biosciences in Q2 2022 and held it in 7 quarters.
  • Great Lakes Advisors's Harmony Biosciences position peaked at $13.3M in Q1 2023.
  • 208 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2024.

Based on Great Lakes Advisors's 13F filing for Q1 2024, filed 8 May 2024.